Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
Abstract WE CONSTANTLY search for new or improved medication which will relieve pain and speed healing. In treating corneal diseases we often partially defeat one purpose to accomplish another. Some of our commonly used agents, for example, tetracaine and hydrous wool fat U. S. P. (lanolin), while relieving pain or serving as a vehicle, may delay corneal healing. If we can find an agent which both relieves pain and stimulates or supports healing, we shall come close to an ideal medicine for treating corneal disease. In thromboplastin we have such an agent. When properly used, it relieves pain quickly and permits rapid replacement of corneal epithelium. My colleagues and I have used it in the treatment of about 100 corneal lesions of various types, with very satisfying clinical results. We have also attempted to verify the work in laboratory animals, with some encouraging and stimulating experiments. The material we used in References 1. Parke, Davis & Company, Thrombin Topical (bovine origin), 5 cc. 2. Sharp & Dohme, Inc., Lyovac Normal Human Plasma.
A.M.A. Archives of Ophthalmology – American Medical Association
Published: May 1, 1954
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.